OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Long Non-coding RNAs on Bladder Cancer
Hui-Jin Li, Xue Gong, Zhengkun Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism
Peihua Liu, Benyi Fan, Belaydi Othmane, et al.
Theranostics (2022) Vol. 12, Iss. 14, pp. 6291-6307
Open Access | Times Cited: 42

Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies
Amirreza Mehmandar‐Oskuie, Kasra Jahankhani, Arman Rostamlou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115242-115242
Open Access | Times Cited: 28

The current status of miRNA in urinary bladder cancer: A minireview and strength, weakness, opportunity, and threat analysis
R. M. Tripathy, Lalit Kumar, Sukhad Kural, et al.
Indian Journal of Urology (2025) Vol. 41, Iss. 2, pp. 98-103
Open Access | Times Cited: 1

Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
Chen Chen, Anquan Shang, Zujun Sun, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 25

lncRNA-mediated ceRNA network in bladder cancer
Kun Li, Tongyue Yao, Ziqiang Wang
Non-coding RNA Research (2022) Vol. 8, Iss. 2, pp. 135-145
Open Access | Times Cited: 23

An Overview of Angiogenesis in Bladder Cancer
Ghada Elayat, Ivan Punev, Abdel Selim
Current Oncology Reports (2023) Vol. 25, Iss. 7, pp. 709-728
Open Access | Times Cited: 15

The Role of Long Chain Non Coding RNA Mediated ceRNA Network in Bladder Cancer
红丽 赵
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 1369-1376
Closed Access

Potential roles of lncRNA-XIST/miRNAs/mRNAs in human cancer cells
Maryam Farzaneh, Ava Nasrolahi, Farhoodeh Ghaedrahmati, et al.
Clinical & Translational Oncology (2023) Vol. 25, Iss. 7, pp. 2015-2042
Closed Access | Times Cited: 9

A review on the roles and molecular mechanisms of MAFG-AS1 in oncogenesis
Khazar Ghasempour Dabbaghi, Noushin Mashatan, Omid Faraz, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154348-154348
Closed Access | Times Cited: 7

A novel LINC02321 promotes cell proliferation and decreases cisplatin sensitivity in bladder cancer by regulating RUVBL2
Chuncheng Lu, Hongbin Gao, Haiyuan Li, et al.
Translational Oncology (2024) Vol. 45, pp. 101962-101962
Open Access | Times Cited: 2

Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
Mehrdad Hashem, Elaheh Mohandesi Khosroshahi, Melika Aliahmady, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 560-582
Open Access | Times Cited: 2

LncRNA polymorphisms and urologic cancer risk
Esmat Abdi, Saeid Latifi‐Navid
Environmental and Molecular Mutagenesis (2022) Vol. 63, Iss. 4, pp. 190-203
Closed Access | Times Cited: 9

Non-coding RNA and autophagy: Finding novel ways to improve the diagnostic management of bladder cancer
Ishaq Tantray, Rani Ojha, Aditya Sharma
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 4

Bladder cancer biomarkers: current approaches and future directions
Melika Ahangar, Frouzandeh Mahjoubi, Seyed Javad Mowla
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1

LncRNA GATA3-AS1 Promotes Bladder Uroepithelial Cancer Progression by Stabilizing DDX5
Yong Duan, Zonghang Liu, Yongliang Ma, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 835-847
Open Access | Times Cited: 1

m 6 A-Mediated Upregulation of lncRNA RMRP Boosts the Progression of Bladder Cancer Via Epigenetically Suppressing SCARA5
Xinsheng Lu, Libo Chen, Shucheng Liu, et al.
Epigenomics (2023) Vol. 15, Iss. 7, pp. 401-415
Closed Access | Times Cited: 3

N6-methyladenosine-related lncRNAs in combination with computational histopathology and radiomics predict the prognosis of bladder cancer
Ziye Huang, Guang Wang, Yuyun Wu, et al.
Translational Oncology (2022) Vol. 27, pp. 101581-101581
Open Access | Times Cited: 4

Unveiling therapeutic prospects: targeting MDM-2 in non-muscle invasive bladder cancer
Hongjian Wu, Hui Jin, Yongjian Cai
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-10
Closed Access

Exosomal RNA and autophagy
Sougata Ghosh Chowdhury, Parimal Karmakar
Elsevier eBooks (2024), pp. 111-134
Closed Access

Chemotherapy Resistance in Cancer: Mechanism and Roadmap to Evade Exploring Apoptosis
Kalpataru Halder
International Journal of Advancement in Life Sciences Research (2024) Vol. 07, Iss. 02, pp. 17-40
Open Access

Epigenetic regulation in muscle-invasive urothelial carcinoma of the bladder in the dog, a translational model of human cancer
Maria Malvina Tsamouri, Michael S. Kent, Maria Mudryj, et al.
Veterinary oncology. (2024) Vol. 1, Iss. 1
Open Access

Epigenetic Biomarkers as a New Diagnostic Tool in Bladder Cancer—From Early Detection to Prognosis
Natalia Jaszek, Alicja Bogdanowicz, Jan Siwiec, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7159-7159
Open Access

LINC01137/miR-186-5p/WWOX: a novel axis identified from WWOX-related RNA interactome in bladder cancer
Damian Kołat, Żaneta Kałuzińska‐Kołat, Katarzyna Kośla, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top